Home Forums Marketplace Table of Contents Events Member List Site Map Register Mark Forums Read



Welcome to the Podiatry Arena forums, for communication between foot health professionals about podiatry and related topics.

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members (PM), upload content, view attachments, receive a weekly email update of new discussions, earn CPD points and access many other special features. Registered users do not get displayed the advertisments in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

If you have any problems with the registration process or your account login, please contact contact us.


Study Finds Discontinuation Of Rosiglitazone Left Many Diabetes Patients Without Good Glycemic Control

Reply
Submit Thread >  Submit to Digg Submit to Reddit Submit to Furl Submit to Del.icio.us Submit to Google Submit to Yahoo! This Submit to Technorati Submit to StumbleUpon Submit to Spurl Submit to Netscape  < Submit Thread
 
Thread Tools Display Modes
  #1  
Old 15th April 2009, 04:40 AM
RSSFeedBot RSSFeedBot is offline
I, Robot
 
About:
Join Date: Jul 2008
Posts: 3,061
Join Date: Jul 2008
Marketplace reputation 0% (0)
CPD Points: 1
Thanks: 0
Thanked 5 Times in 5 Posts
Default Study Finds Discontinuation Of Rosiglitazone Left Many Diabetes Patients Without Good Glycemic Control

Podiatry Arena members do not see these ads
When concerns were raised about the safety of the diabetes medication, rosiglitazone, in May 2007, many patients and their doctors made the decision to discontinue use of the drug. A study published in Endocrine Practice by Dr. Etta Fanning from the University of Texas Health Science Center along with her colleagues reported that many patients who discontinued use of rosiglitazone received less therapy and higher blood glucose levels as a result.

More...
Reply With Quote
Sponsored Links
Reply



Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
vB code is On
Smilies are On
[IMG] code is On
HTML code is On
Forum Jump

Translate This Page

Similar Threads
Thread Thread Starter Forum Replies Last Post
Running May Provide More Benefits To Bones Than Resistance Training, MU Study Finds RSSFeedBot Latest Sports Medicine News 0 2nd March 2009 06:20 AM
Pre-Activity Stretching May Hinder Athletic Performance, Unlv Study Finds RSSFeedBot Latest Sports Medicine News 0 22nd September 2008 04:20 AM


New To Site? Need Help?

Finding your way around:

Browse the forums.

Search the site.

Browse the tags.

Search the tags.


All times are GMT -7. The time now is 03:42 PM.